🇺🇸 FDA
Patent

US 7951362

Compositions and methods of use of targeting peptides against placenta and adipose tissues

granted A61KA61K31/70A61K38/08

Quick answer

US patent 7951362 (Compositions and methods of use of targeting peptides against placenta and adipose tissues) held by The Board of Regents of the University of Texas System expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/70, A61K38/08, A61P, A61P3/04